Controller clears clot-buster drug for human trialAugust 17th, 2012 - 7:28 pm ICT by IANS
New Delhi/Chandigarh, Aug 17 (IANS) The Drug Controller General of India (DCGI) has cleared a bio-therapeutic clot-buster drug for phase-one human clinical trials, a statement said Friday.
The drug, earlier licensed from a US-based firm, has been designed by Chandigarh-based Council of Scientific and Industrial Research (CSIR) - Institute of Microbial Technology (CSIR-IMTECH).
“Clot-specific streptokinase (CSSK), a pioneering bio-therapeutic clot buster drug from the CSIR-IMTECH has been cleared Thursday by the office of the DCGI for Phase-One Human Clinical trials,” the statement from CSIR said.
The drug is helpful in saving lives of patients suffering heart attacks; it can also reduce the risk of internal bleeding, associated with the use of clot busters.
The drug has recently been successfully tried in test animals including monkeys. Its design and process development and scale-up was achieved by a team led by CSIR-IMTECH Director Girish Sahni.
- CSIR launches new cardiac drug in Indian market - Jul 10, 2009
- Bharat Biotech begins phase III trials of clot-busting drug - Feb 04, 2011
- Chandigarh Research Institute develops medicine for clots busting linked to heart attacks - Aug 08, 2009
- New device removes clots from brain - Aug 27, 2012
- US'' pharmaceutical company obtains licensing rights from IMTECH - Feb 24, 2009
- Clinical drug trial centres in Andhra to be probed - Jun 25, 2011
- Clot busting drug could improve stroke treatment - May 29, 2011
- Chandigarh lab, northeast varsity work on cancer detector - Dec 01, 2011
- GVK Bio's Ahmedabad facility cleared by USFDA - Jul 30, 2012
- Drug from Indian spice builds brain cells after stroke - Feb 10, 2011
- Bat's saliva to cure stroke victims - Sep 04, 2011
- Clot busting therapy more critical for female stroke victims - Mar 02, 2010
- Stent like device effective for removing blood clots - Feb 06, 2012
- Life work culminates in testing of cancer therapy in humans - Mar 24, 2011
- Panel to look into irregularities in drug trials - May 11, 2012
Tags: chandigarh, clot buster, clot busters, controller general, dcgi, heart attacks, human clinical trials, imtech, India, microbial technology, monkeys, New Delhi, phase one, risk, streptokinase, suffering heart, test animals